Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2026-02-25 @ 12:57 AM
Study NCT ID:
NCT06718335
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-12-11
First Post:
2024-10-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pyrotinib in HER2-positive Early Breast Cancer
Sponsor:
Nie Jianyun
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OBU-BC-YUNNAN-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None